Search Count: 32
![]() |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-05-07 Classification: MEMBRANE PROTEIN |
![]() |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-05-07 Classification: MEMBRANE PROTEIN |
![]() |
Structure Of Ptp1B Complexed With N-(3'-(1,1-Dioxido-4-Oxo-1,2,5-Thiadiazolidin-2-Yl)-4'-Methyl-[1,1'-Biphenyl]-4-Yl)Acetamide
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2017-04-12 Classification: HYDROLASE Ligands: MG, 73U, CL |
![]() |
Structure Of Wild-Type Igg1 Antibody Heavy Chain Constant Domain 1 And Light Chain Lambda Constant Domain (Igg1 Ch1:Clambda) At 1.19A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.19 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM |
![]() |
Structure Of Redesigned Igg1 First Constant And Lambda Domains (Ch1:Clambda Constant Redesign 1, Crd1) At 1.75A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM |
![]() |
Structure Of Redesigned Igg1 First Constant And Lambda Domains (Ch1:Clambda Constant Redesign 2 Beta, Crd2B) At 1.42A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.42 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM Ligands: PG6 |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM Ligands: SO4, ACT |
![]() |
Crystal Structure Of Pertuzumab Clambda Fab With Variable Domain Redesign (Vrd2) At 1.95A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM Ligands: SO4 |
![]() |
Crystal Structure Of Pertuzumab Clambda Fab With Variable And Constant Domain Redesigns (Vrd2 And Crd2) At 1.6A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2014-01-29 Classification: IMMUNE SYSTEM Ligands: GOL, MG |
![]() |
Structure Of An Rsp5Xubxsna3 Complex: Mechanism Of Ubiquitin Ligation And Lysine Prioritization By A Hect E3
Organism: Saccharomyces cerevisiae, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2013-08-14 Classification: Ligase/protein binding |
![]() |
Organism: Bacillus amyloliquefaciens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2013-04-10 Classification: OXIDOREDUCTASE |
![]() |
Bacillus Amyloliquefaciens Cbm33 In Complex With Cu(I) After Photoreduction
Organism: Bacillus amyloliquefaciens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2013-04-10 Classification: OXIDOREDUCTASE Ligands: CU1 |
![]() |
Bacillus Amyloliquefaciens Cbm33 In Complex With Cu(I) Reduced Using Ascorbate
Organism: Bacillus amyloliquefaciens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2013-04-10 Classification: OXIDOREDUCTASE Ligands: CU1, EDO |
![]() |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2011-10-19 Classification: HYDROLASE Ligands: MG |
![]() |
Organism: Homo sapiens, Hirudo medicinalis
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2008-03-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: T15 |
![]() |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2005-09-27 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 382 |
![]() |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2005-09-27 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 501 |
![]() |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2005-06-07 Classification: BLOOD CLOTTING,HYDROLASE/INHIBITOR Ligands: 062 |
![]() |
Organism: Hirudo medicinalis, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2005-05-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: L17 |
![]() |
Crystal Structue Of Thrombin In Complex With A Potent P1 Heterocycle-Aryl Based Inhibitor
Organism: Homo sapiens, Hirudo medicinalis
Method: X-RAY DIFFRACTION Resolution:1.81 Å Release Date: 2004-08-03 Classification: BLOOD CLOTTING,HYDROLASE/INHIBITOR Ligands: 170 |